AU2002365136A1 - Compositions and methods for controlled release - Google Patents
Compositions and methods for controlled releaseInfo
- Publication number
- AU2002365136A1 AU2002365136A1 AU2002365136A AU2002365136A AU2002365136A1 AU 2002365136 A1 AU2002365136 A1 AU 2002365136A1 AU 2002365136 A AU2002365136 A AU 2002365136A AU 2002365136 A AU2002365136 A AU 2002365136A AU 2002365136 A1 AU2002365136 A1 AU 2002365136A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- controlled release
- release
- controlled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33634401P | 2001-10-18 | 2001-10-18 | |
US60/336,344 | 2001-10-18 | ||
PCT/US2002/033558 WO2003060142A2 (en) | 2001-10-18 | 2002-10-17 | Compositions and methods for controlled release |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002365136A1 true AU2002365136A1 (en) | 2003-07-30 |
AU2002365136A8 AU2002365136A8 (en) | 2003-07-30 |
Family
ID=23315656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002365136A Abandoned AU2002365136A1 (en) | 2001-10-18 | 2002-10-17 | Compositions and methods for controlled release |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1446008A4 (en) |
JP (1) | JP2005523890A (en) |
AU (1) | AU2002365136A1 (en) |
CA (1) | CA2464131A1 (en) |
WO (1) | WO2003060142A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009145813A1 (en) | 2008-03-04 | 2009-12-03 | Qd Vision, Inc. | Particles including nanoparticles, uses thereof, and methods |
KR101865888B1 (en) | 2009-09-09 | 2018-06-08 | 삼성전자주식회사 | Particles including nanoparticles, uses thereof, and methods |
WO2011031876A1 (en) | 2009-09-09 | 2011-03-17 | Qd Vision, Inc. | Formulations including nanoparticles |
DE102009058769A1 (en) * | 2009-12-16 | 2011-06-22 | MagForce Nanotechnologies AG, 10589 | Temperature-dependent activation of catalytic nucleic acids for controlled drug release |
JP2016183434A (en) * | 2015-03-26 | 2016-10-20 | 国立大学法人京都大学 | Surface modification substrate |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985554A (en) * | 1994-11-02 | 1999-11-16 | Takeda Chemical Industries, Ltd. | Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides |
AU734827B2 (en) * | 1997-05-21 | 2001-06-21 | Board Of Trustees Of The Leland Stanford Junior University | Composition and method for enhancing transport across biological membranes |
WO1999050462A1 (en) * | 1998-03-27 | 1999-10-07 | President And Fellows Of Harvard College | Aptamer based bacterial inhibition systems (abbis) |
US6333194B1 (en) * | 1999-01-19 | 2001-12-25 | The Children's Hospital Of Philadelphia | Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof |
US6395029B1 (en) * | 1999-01-19 | 2002-05-28 | The Children's Hospital Of Philadelphia | Sustained delivery of polyionic bioactive agents |
US6232068B1 (en) * | 1999-01-22 | 2001-05-15 | Rosetta Inpharmatics, Inc. | Monitoring of gene expression by detecting hybridization to nucleic acid arrays using anti-heteronucleic acid antibodies |
WO2001024775A1 (en) * | 1999-10-01 | 2001-04-12 | Essentia Biosystems, Inc. | Gel-forming compositions |
IN2014DN10834A (en) * | 2001-09-17 | 2015-09-04 | Psivida Inc | |
US20030134811A1 (en) * | 2001-10-09 | 2003-07-17 | John Jackson | Methods and compositions comprising hydroxyapatite useful for the administration of therapeutic agents |
-
2002
- 2002-10-17 WO PCT/US2002/033558 patent/WO2003060142A2/en active Application Filing
- 2002-10-17 CA CA002464131A patent/CA2464131A1/en not_active Abandoned
- 2002-10-17 AU AU2002365136A patent/AU2002365136A1/en not_active Abandoned
- 2002-10-17 JP JP2003560224A patent/JP2005523890A/en active Pending
- 2002-10-17 EP EP02803289A patent/EP1446008A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2003060142A2 (en) | 2003-07-24 |
WO2003060142A9 (en) | 2003-08-21 |
EP1446008A4 (en) | 2006-08-16 |
WO2003060142A3 (en) | 2004-02-12 |
CA2464131A1 (en) | 2003-07-24 |
EP1446008A2 (en) | 2004-08-18 |
AU2002365136A8 (en) | 2003-07-30 |
JP2005523890A (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002300377A1 (en) | Compositions for controlled release | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
GB0218157D0 (en) | Compositions for controlled release | |
AU2002229140A1 (en) | Controlled release pharmaceutical composition | |
AU2002361623A1 (en) | Methods and compositions for chromatography | |
AU2001293189A1 (en) | Compositions and methods for regulating apoptosis | |
AU2002364708A1 (en) | Novel compositions and methods for cancer | |
AU2002241114A1 (en) | Composition | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2002351388A1 (en) | Methods and compositions for controlled release of drugs | |
AU2002215333A1 (en) | Compositions for release of radiosensitizers, and methods of making and using the same | |
AU2002359694A1 (en) | Compounds and methods | |
AU2002345878A1 (en) | Ilt3 and ilt4-related compositions and methods | |
AU2002337943A1 (en) | Novel compositions and methods for cancer | |
AU2002365136A1 (en) | Compositions and methods for controlled release | |
AU2003212866A1 (en) | Controlled release compositions and methods for using same | |
AU2002245510A1 (en) | Method and composition for embalming | |
AU2001283226A1 (en) | Methods and compositions for inhibiting rad51 | |
AU2003275240A1 (en) | Methods and compositions for soluble cpg15 | |
AU2002359869A1 (en) | Pak5-related compositions and methods | |
AU2002246221A1 (en) | Method and composition | |
AU2002307070A1 (en) | Method and composition for controlled release acarbose formulations | |
AUPQ994800A0 (en) | Compositions and methods for immunotherapy | |
AUPQ821300A0 (en) | Compositions and methods for immunotherapy | |
AU2002338412A1 (en) | Controlled release particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |